India has described new cases of Covid-19 as new sub-regions nb.1.8.1 and LF.7, which is being found in various parts of the country in both parts of the developed Omikron dynasty.

According to data from the Indian Sars-Cov-2 Genomics Consortium (Insacog), a case of NB.1.8.1 was found in Tamil Nadu in April, while in May, four cases of LF.7 were reported in Gujarat.

The latest Noida to join the list is a 55 -year -old woman from Uttar Pradesh, who conducted a positive test for Kovid -19, which marks the first confirmed case of the district in the current Serge.

Chief Medical Officer of Gautam Buddha Nagar, Dr. According to Narendra Kumar, the woman, who recently traveled by train, is in home isolation and close contacts have conducted a negative test.

Meanwhile, Meimes Rishikesh also reported three Kovid -19 cases, one of which has been discharged, while the other is subject to observation.

Director of AIIMS Rishikesh, Dr. According to Meenu Singh, the current version is “not very harmful,” but caution is still advised, especially for people with comoridity.

What are NB.1.8.1 and LF.7? Are they more broadcast?

Both are sub-linage of NB.1.8.1 and LF.7 JN.1 variants, which is the most prominent stress in India, accounting for 53% of all indexed samples.

These sub-variants are monitored by the World Health Organization (WHO) as ‘as a variant’ under monitoring, meaning that they have mutations that can affect the behavior of the virus, but have not yet been classified as the ‘variant of anxiety’ or ‘variants of interest’.

Studies in early stages and expert assessments suggest that these sub-variants are more broadcast and have more ability to avoid immune prevention than earlier strains.

For example, NB.1.8.1 has a notable spike protein mutation called A435S, V445H, and T478i, which can increase both its infectious and immune theft capabilities.

JN.1 The only dynasty bears the L455S mutation, which is estimated to make 1.5 times more infectious than the previous variants.

Despite these symptoms, the severity of the disease caused by these sub -divisions seems to be less.

“Most cases remain light with low hospitalized rates,” Dr. Arup Halder said, Pulmonologist at CMRI Hospital, Kolkata.

He said that the increase in cases is largely due to increasing identity due to immunity, uneven booster coverage and better monitoring.

Should you be worried?

As of May 19, there were 257 active Kovid -19 cases in India. States such as Kerala, Maharashtra, and Tamil Nadu emerged as hotspots, in which most cases were reported in cities such as Mumbai, Pune and Thane. Kerala alone logged 273 cases in May.

Delhi has also issued advice to hospitals to ensure the availability of beds, oxygen, medicines and vaccines in view of the increasing number.

Senior Advisor in Internal Medicine at Indraprastha Apollo Hospital. Suranjit Chatterjee told ANI, “At this time, the situation is under control. There is no need to panic.”

Although new version-specific vaccines are not yet available in India, existing boosters can still provide strong security. Dr. According to the hallor, these boosters can reduce the risk of symptomatic infection by 50% and 80% from serious illness.

According to the expert, India has so far given more than 2.2 billion doses of Covid-19 vaccines, but the booster uttake is inconsistent, especially among the weaker population.

“The vaccine is inspired by hesitation, misinformation and logical challenges, a dull issue,” Dr. Halder said.

Experts recommend that the elderly and high -risk individuals with underlying health conditions receive their booster dose immediately.

“It is important that high-risk individuals get immediate boost, continue masking in crowded places, and follow the basic hygiene practices,” Dr. Halder said.